- Inovativní léčba fenylketonurie sapropterinem2018 | 3. lékařská fakulta
- Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial2021 | 3. lékařská fakulta
- Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients < 4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial2017 | Ústřední knihovna